Treatment and prescribing trends of antihypertensive drugs in 2.7 million UK primary care patients over 31 years: a population-based cohort study
Objectives To describe the prescribing trends of antihypertensive drugs in primary care patients
and assess the trajectory of antihypertensive drug prescriptions, from first-line to third-line…
and assess the trajectory of antihypertensive drug prescriptions, from first-line to third-line…
Use of hydrochlorothiazide and risk of melanoma and nonmelanoma skin cancer
J Rouette, H Yin, A Pottegård, K Nirantharakumar… - Drug Safety, 2021 - Springer
Introduction There are concerns that hydrochlorothiazide may increase the risk of incident
nonmelanoma (cutaneous squamous cell carcinoma [cSCC], basal cell carcinoma [BCC]) and …
nonmelanoma (cutaneous squamous cell carcinoma [cSCC], basal cell carcinoma [BCC]) and …
Dipeptidyl peptidase 4 inhibitors and the risk of bullous pemphigoid among patients with type 2 diabetes
A Douros, J Rouette, H Yin, OHY Yu, KB Filion… - Diabetes …, 2019 - Am Diabetes Assoc
OBJECTIVE There are uncertainties regarding the association between dipeptidyl peptidase
4 (DPP-4) inhibitors and bullous pemphigoid (BP), a potentially severe autoimmune skin …
4 (DPP-4) inhibitors and bullous pemphigoid (BP), a potentially severe autoimmune skin …
Graphical displays of patient-reported outcomes (PRO) for use in clinical practice: What makes a pro picture worth a thousand words?
Patient-reported outcomes (PROs) report patients’ assessments of the impact of a health
condition and its treatment, and can promote patient-centered care. Objectives To address the …
condition and its treatment, and can promote patient-centered care. Objectives To address the …
Preliminary evidence on the uptake, use and benefits of the CONSORT-PRO extension
R Mercieca-Bebber, J Rouette, M Calvert, MT King… - Quality of Life …, 2017 - Springer
Purpose This study assessed the uptake of the CONsolidated Standards of Reporting Trials
(CONSORT)—Patient-Reported Outcomes (PRO) statement; determined if use of CONSORT…
(CONSORT)—Patient-Reported Outcomes (PRO) statement; determined if use of CONSORT…
Thiazide Diuretics and Risk of Colorectal Cancer: A Population-Based Cohort Study
J Rouette, EG McDonald, T Schuster… - American Journal of …, 2024 - academic.oup.com
Evidence from clinical trials and observational studies on the association between thiazide
diuretics and colorectal cancer risk is conflicting. We aimed to determine whether thiazide …
diuretics and colorectal cancer risk is conflicting. We aimed to determine whether thiazide …
Directly improving the quality of radiation treatment through peer review: A cross-sectional analysis of cancer centers across a provincial cancer program
J Rouette, E Gutierrez, J O'Donnell… - International Journal of …, 2017 - Elsevier
Purpose To describe the outcomes of peer review across all 14 cancer centers in Ontario.
Methods and Materials We identified all peer-reviewed, curative treatment plans delivered in …
Methods and Materials We identified all peer-reviewed, curative treatment plans delivered in …
Integrating health-related quality of life findings from randomized clinical trials into practice: an international study of oncologists' perspectives
Purpose Although health-related quality of life (HRQL) is increasingly assessed in randomized
controlled trials (RCTs), HRQL findings are not always incorporated into clinical decision …
controlled trials (RCTs), HRQL findings are not always incorporated into clinical decision …
A pan-Canadian survey of peer review practices in radiation oncology
A Caissie, J Rouette, P Jugpal, CA Davis… - Practical radiation …, 2016 - Elsevier
Purpose Peer review (PR) of treatment plans has been recognized internationally as a key
component of quality care in radiation oncology programs (ROPs). We conducted a survey of …
component of quality care in radiation oncology programs (ROPs). We conducted a survey of …
Recommendations for the use of propensity score methods in multiple sclerosis research
…, F Pellegrini, TPA Debray, J Rouette… - Multiple Sclerosis …, 2022 - journals.sagepub.com
Background: With many disease-modifying therapies currently approved for the management
of multiple sclerosis, there is a growing need to evaluate the comparative effectiveness …
of multiple sclerosis, there is a growing need to evaluate the comparative effectiveness …